THNR vs. PJP
THNR (Amplify Weight Loss Drug & Treatment ETF) and PJP (Invesco Dynamic Pharmaceuticals ETF) are both Health & Biotech Equities funds - THNR tracks the VettaFi Weight Loss Drug & Treatment Index while PJP tracks the Dynamic Pharmaceuticals Intellidex Index. Both are passively managed. Over the past year, THNR returned 13.81% vs 49.30% for PJP. Their 0.70 correlation means they have sometimes moved together and sometimes differently. THNR charges 0.59%/yr vs 0.58%/yr for PJP.
Performance
THNR vs. PJP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, THNR achieves a 0.29% return, which is significantly lower than PJP's 17.06% return.
THNR
- 1D
- -0.40%
- 1M
- -4.22%
- 6M
- -4.09%
- YTD
- 0.29%
- 1Y
- 13.81%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 0.92%
PJP
- 1D
- 0.21%
- 1M
- 0.66%
- 6M
- 14.14%
- YTD
- 17.06%
- 1Y
- 49.30%
- 3Y*
- 17.12%
- 5Y*
- 9.41%
- 10Y*
- 6.98%
- ALL TIME*
- 11.75%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $6.54M | $7.65M | $3.59M | |
| $30.02K | $44.27K | $50.07K |
THNR vs. PJP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
THNR Amplify Weight Loss Drug & Treatment ETF | 0.29% | 13.65% | -10.47% |
PJP Invesco Dynamic Pharmaceuticals ETF | 17.06% | 27.98% | 3.03% |
Correlation
The correlation between THNR and PJP is 0.70, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.70 |
Correlation (All Time) Calculated using the full available price history since May 21, 2024 | 0.70 |
The correlation between THNR and PJP has been stable across timeframes, ranging from 0.70 to 0.70 - a consistent structural relationship.
THNR vs. PJP - Sectors Allocation Comparison
Sectors
THNR
PJP
Healthcare
Financial Services
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
THNR
PJP
Financial Services
THNR
PJP
Basic Materials
THNR
-
PJP
-
Communication Services
THNR
-
PJP
-
Consumer Cyclical
THNR
-
PJP
-
Consumer Defensive
THNR
-
PJP
-
Energy
THNR
-
PJP
-
Industrials
THNR
-
PJP
-
Real Estate
THNR
-
PJP
-
Technology
THNR
-
PJP
-
Utilities
THNR
-
PJP
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
THNR vs. PJP — Risk / Return Rank
THNR
PJP
THNR vs. PJP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amplify Weight Loss Drug & Treatment ETF (THNR) and Invesco Dynamic Pharmaceuticals ETF (PJP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| THNR | PJP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.22 | ||
| Sortino ratioReturn per unit of downside risk | -2.97 | ||
| Omega ratioGain probability vs. loss probability | 1.14 | 1.49 | -0.35 |
| Calmar ratioReturn relative to maximum drawdown | 1.15 | 5.25 | -4.10 |
| Martin ratioReturn relative to average drawdown | 2.57 | 16.43 | -13.86 |
Loading charts...
Drawdowns
THNR vs. PJP - Drawdown Comparison
The maximum THNR drawdown since its inception was -32.51%, smaller than the maximum PJP drawdown of -37.06%. Use the drawdown chart below to compare losses from any high point for THNR and PJP.
Loading charts...
Drawdown Indicators
| THNR | PJP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -32.51% | -37.06% | +4.55% |
Max Drawdown (1Y)Largest decline over 1 year | -12.06% | -9.44% | -2.62% |
Max Drawdown (3Y)Largest decline over 3 years | — | -16.27% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -17.51% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.95% | — |
Current DrawdownCurrent decline from peak | -7.96% | -0.89% | -7.07% |
Average DrawdownAverage peak-to-trough decline | -11.90% | -8.79% | -3.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.39% | 3.01% | +2.38% |
Volatility
THNR vs. PJP - Volatility Comparison
The current volatility for Amplify Weight Loss Drug & Treatment ETF (THNR) is 4.17%, while Invesco Dynamic Pharmaceuticals ETF (PJP) has a volatility of 5.29%. This indicates that THNR experiences smaller price fluctuations and is considered to be less risky than PJP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| THNR | PJP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.17% | 5.29% | -1.12% |
Volatility (6M)Calculated over the trailing 6-month period | 14.06% | 13.25% | +0.81% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.92% | 16.79% | +2.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.27% | 16.37% | +2.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.27% | 18.39% | +0.88% |
THNR vs. PJP - Expense Ratio Comparison
THNR has a 0.59% expense ratio, which is higher than PJP's 0.58% expense ratio.
Dividends
THNR vs. PJP - Dividend Comparison
THNR's dividend yield for the trailing twelve months is around 1.63%, more than PJP's 0.88% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 0.88% | 0.98% | 0.97% | 1.01% | 0.95% | 0.81% | 0.75% | 0.77% | 1.12% | 0.65% | 0.91% | 5.49% |
THNR Amplify Weight Loss Drug & Treatment ETF | 1.63% | 1.64% | 0.98% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
THNR and PJP have a correlation of 0.70, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PJP has higher volatility (5.29%) compared to THNR (4.17%). In terms of maximum drawdown, THNR dropped -32.51% vs PJP's -37.06%.
On 1-year performance, PJP leads with 49.30% vs 13.81% for THNR. On fees, PJP is cheaper at 0.58% per year. On volatility, THNR has been the lower-risk option at 4.17%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, PJP has performed better with a 49.30% return vs 13.81%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PJP is cheaper with a 0.58% expense ratio, compared with 0.59% for THNR.
THNR has the higher dividend yield at 1.63%, compared with 0.88% for PJP.
THNR tracks VettaFi Weight Loss Drug & Treatment Index, while PJP tracks Dynamic Pharmaceuticals Intellidex Index. They also come from different issuers: Amplify and Invesco. Their fees differ too: 0.59% for THNR and 0.58% for PJP.
PJP currently has the higher Sharpe Ratio (2.96 vs 0.73), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for THNR and PJP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer